Distinct Phosphotyrosine-dependent Functions of the ShcA Adaptor Protein Are Required for Transforming Growth Factor β (TGFβ)-induced Breast Cancer Cell Migration, Invasion, and Metastasis*
暂无分享,去创建一个
T. Pawson | Z. Dong | P. Siegel | W. R. Hardy | J. J. Northey | A. Kaplan | E. Ngan | Zhifeng Dong | Peter M. Siegel
[1] C. Arteaga,et al. When Tumor Suppressor TGFβ Meets the HER2 (ERBB2) Oncogene , 2011, Journal of Mammary Gland Biology and Neoplasia.
[2] P. Provero,et al. p130Cas promotes invasiveness of three-dimensional ErbB2-transformed mammary acinar structures by enhanced activation of mTOR/p70S6K and Rac1. , 2011, European journal of cell biology.
[3] T. Pawson,et al. Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response. , 2010, Cancer research.
[4] G. Forni,et al. p130Cas is an essential transducer element in ErbB2 transformation , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] L. Deshmukh,et al. Integrin β3 Phosphorylation Dictates Its Complex with the Shc Phosphotyrosine-binding (PTB) Domain* , 2010, The Journal of Biological Chemistry.
[6] F. Pépin,et al. ADAM10 Releases a Soluble Form of the GPNMB/Osteoactivin Extracellular Domain with Angiogenic Properties , 2010, PloS one.
[7] R. Cardiff,et al. CrkII transgene induces atypical mammary gland development and tumorigenesis. , 2010, The American journal of pathology.
[8] Michael K. Wendt,et al. p130Cas Is Required for Mammary Tumor Growth and Transforming Growth Factor-β-mediated Metastasis through Regulation of Smad2/3 Activity* , 2009, The Journal of Biological Chemistry.
[9] A. Pozzi,et al. Transforming growth factor beta induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton. , 2009, Cancer research.
[10] Carlos L. Arteaga,et al. Transforming Growth Factor (cid:2) Engages TACE and ErbB3 To Activate Phosphatidylinositol-3 Kinase/Akt in ErbB2-Overexpressing Breast Cancer and Desensitizes Cells to Trastuzumab (cid:1) † , 2008 .
[11] T. Pawson,et al. ShcA signalling is essential for tumour progression in mouse models of human breast cancer , 2008, The EMBO journal.
[12] W. Muller,et al. Signaling through ShcA Is Required for Transforming Growth Factor β- and Neu/ErbB-2-Induced Breast Cancer Cell Motility and Invasion , 2008, Molecular and Cellular Biology.
[13] Jing Qing,et al. TGF‐β activates Erk MAP kinase signalling through direct phosphorylation of ShcA , 2007 .
[14] J. Fawcett,et al. Combinatorial ShcA Docking Interactions Support Diversity in Tissue Morphogenesis , 2007, Science.
[15] J. Trepel,et al. Inhibition of tumor metastasis by a growth factor receptor bound protein 2 Src homology 2 domain-binding antagonist. , 2007, Cancer research.
[16] T. Pawson,et al. Screening for PTB Domain Binding Partners and Ligand Specificity Using Proteome-Derived NPXY Peptide Arrays , 2007, Molecular and Cellular Biology.
[17] W. Schiemann,et al. Src phosphorylates Tyr284 in tgf-β type II receptor and regulates TGF-β stimulation of p38 MAPK during breast cancer cell proliferation and invasion , 2007 .
[18] D. Sgroi,et al. p66 Shc and tyrosine-phosphorylated Shc in primary breast tumors identify patients likely to relapse despite tamoxifen therapy , 2006, Breast Cancer Research.
[19] William P Schiemann,et al. β3 Integrin and Src facilitate transforming growth factor-β mediated induction of epithelial-mesenchymal transition in mammary epithelial cells , 2006, Breast Cancer Research.
[20] A. Sapino,et al. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. , 2006, Cancer research.
[21] Mingjian Lu,et al. Dock180-ELMO cooperation in Rac activation. , 2006, Methods in enzymology.
[22] S. Lowe,et al. Probing tumor phenotypes using stable and regulated synthetic microRNA precursors , 2005, Nature Genetics.
[23] C. Heldin,et al. Non-Smad TGF-β signals , 2005, Journal of Cell Science.
[24] R. Birge,et al. C‐terminal SH3 domain of CrkII regulates the assembly and function of the DOCK180/ELMO Rac‐GEF , 2005, Journal of cellular physiology.
[25] Morag Park,et al. CrkI and CrkII Function as Key Signaling Integrators for Migration and Invasion of Cancer Cells , 2005, Molecular Cancer Research.
[26] T. Pawson,et al. The Shc adaptor protein is critical for VEGF induction by Met/HGF and ErbB2 receptors and for early onset of tumor angiogenesis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[27] M. Hengartner,et al. Dock180 and ELMO1 Proteins Cooperate to Promote Evolutionarily Conserved Rac-dependent Cell Migration* , 2004, Journal of Biological Chemistry.
[28] X. Zang,et al. KGF-induced motility of breast cancer cells is dependent on Grb2 and Erk1,2 , 2004, Clinical & Experimental Metastasis.
[29] R. Bagdasaryan,et al. Shc proteins are strong, independent prognostic markers for both node-negative and node-positive primary breast cancer. , 2003, Cancer research.
[30] Ying E. Zhang,et al. Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.
[31] M. Naujokas,et al. Crk Synergizes with Epidermal Growth Factor for Epithelial Invasion and Morphogenesis and Is Required for the Met Morphogenic Program* , 2002, The Journal of Biological Chemistry.
[32] M. Naujokas,et al. Crk adapter proteins promote an epithelial-mesenchymal-like transition and are required for HGF-mediated cell spreading and breakdown of epithelial adherens junctions. , 2002, Molecular biology of the cell.
[33] M. Shibuya,et al. Discrimination between phosphotyrosine-mediated signaling properties of conventional and neuronal Shc adapter molecules , 2002, Oncogene.
[34] W. Muller,et al. Multiple ErbB-2/Neu Phosphorylation Sites Mediate Transformation through Distinct Effector Proteins* , 2001, The Journal of Biological Chemistry.
[35] M. Moran,et al. Grb2 and Shc Adapter Proteins Play Distinct Roles in Neu (ErbB-2)-Induced Mammary Tumorigenesis: Implications for Human Breast Cancer , 2001, Molecular and Cellular Biology.
[36] S. Sadekova,et al. Distinct tyrosine autophosphorylation sites mediate induction of epithelial mesenchymal like transition by an activated ErbB-2/Neu receptor , 2001, Oncogene.
[37] F. Giancotti,et al. Tyrosine Phosphorylation of the β4 Integrin Cytoplasmic Domain Mediates Shc Signaling to Extracellular Signal-regulated Kinase and Antagonizes Formation of Hemidesmosomes* , 2001, The Journal of Biological Chemistry.
[38] T. Pawson,et al. Accelerated Mammary Tumor Development in Mutant Polyomavirus Middle T Transgenic Mice Expressing Elevated Levels of Either the Shc or Grb2 Adapter Protein , 1999, Molecular and Cellular Biology.
[39] Pier Paolo Pandolfi,et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals , 1999, Nature.
[40] R. Cardiff,et al. Elevated expression of activated forms of Neu/ErbB‐2 and ErbB‐3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer , 1999, The EMBO journal.
[41] Tony Pawson,et al. Mammalian Grb2 Regulates Multiple Steps in Embryonic Development and Malignant Transformation , 1998, Cell.
[42] Requirement for Both Shc and Phosphatidylinositol 3′ Kinase Signaling Pathways in Polyomavirus Middle T-Mediated Mammary Tumorigenesis , 1998, Molecular and Cellular Biology.
[43] M. Shibuya,et al. Tyrosine phosphorylation sites at amino acids 239 and 240 of Shc are involved in epidermal growth factor-induced mitogenic signaling that is distinct from Ras/mitogen-activated protein kinase activation , 1997, Molecular and cellular biology.
[44] M. Shibuya,et al. A novel pathway from phosphorylation of tyrosine residues 239/240 of Shc, contributing to suppress apoptosis by IL‐3. , 1996, The EMBO journal.
[45] Tony Pawson,et al. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein–protein interactions , 1996, Current Biology.
[46] T. Pawson,et al. The PTB domain: a new protein module implicated in signal transduction. , 1995, Trends in biochemical sciences.
[47] T Pawson,et al. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. , 1994, Oncogene.
[48] T. Pawson,et al. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1 , 1993, Nature.
[49] Sheila M. Thomas,et al. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases , 1992, Nature.
[50] T. Pawson,et al. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction , 1992, Cell.